\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ radiation\\ and\\ chemotherapy\ \(19\)\
\-\ \\â\\€\\¢\\ enhancing\\ mass\\ medial\\ aspect\\ left\\ temporal\\ lobe\\.\ \(0\)\
\-\ \\â\\€\\¢\\ diffuse\\ enhancement\\ all\\ leptomeningeal\\ surfaces\\ of\\ brain\\ with\\ extension\\ into\\ spinal\\ canal\\.\ \(0\)\
\-\ \\â\\€\\¢\\ abnormal\\ signal\\ intensity\\ of\\ arachnoid\\ spaces\\ on\\ flair\\ imaging\\.\ \(0\)\
\-\ malignant\\ melanoma\\ with\\ diffuse\\ leptomeningeal\\ spread\ \(0\)\
\-\ \\â\\€\\¢\\ meningitis\ \(2\)\
\-\ \\â\\€\\¢\\ sarcoid\ \(3\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ \\â\\€\\¢\\ leptomeningeal\\ carcinomatosis\ \(0\)\
\-\ \\â\\€\\¢\\ leptomeningeal\\ melanocytosis\ \(0\)\
\-\ 38\\ year\\ old\\ woman\\ with\\ a\\ pigmented\\ nevus\\ removed\\ as\\ a\\ child\\,\\ shortly\\ after\\ birth\\.\\ \\ now\\ presents\\ with\\ 5\\ seizures\\ and\\ severe\\ headache\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.24769994174064047\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.1528794489361842\ \(0\)\
\-\ melanocytosis\\:\\ 0\\.09905330784642138\ \(0\)\
\-\ nevus\\:\\ 0\\.07159852981463485\ \(0\)\
\-\ surfaces\\:\\ 0\\.0677734376334758\ \(0\)\
\-\ pigmented\\:\\ 0\\.0664417389509759\ \(0\)\
\-\ carcinomatosis\\:\\ 0\\.06380487177451694\ \(0\)\
\-\ diffuse\\:\\ 0\\.06309774196037353\ \(0\)\
\-\ shortly\\:\\ 0\\.0593204232364033\ \(0\)\
\-\ 38\\:\\ 0\\.05552242130396565\ \(0\)\
\-\ meningitis\\:\\ 0\\.05406697304015386\ \(0\)\
\-\ sarcoid\\:\\ 0\\.05347197103808761\ \(0\)\
\-\ melanoma\\:\\ 0\\.05318501375259744\ \(0\)\
\-\ arachnoid\\:\\ 0\\.052362559108749485\ \(0\)\
\-\ spaces\\:\\ 0\\.051345710219248865\ \(0\)\
\-\ spread\\:\\ 0\\.05040716093710096\ \(0\)\
\-\ birth\\:\\ 0\\.05007302710553859\ \(0\)\
\-\ flair\\:\\ 0\\.047776568585555935\ \(0\)\
\-\ removed\\:\\ 0\\.0469838267525194\ \(0\)\
\-\ child\\:\\ 0\\.045613958643081355\ \(0\)\
\-\ seizures\\:\\ 0\\.04480310813980291\ \(0\)\
\-\ temporal\\:\\ 0\\.04173037655626996\ \(0\)\
\-\ canal\\:\\ 0\\.04140223688651478\ \(0\)\
\-\ non\\-contributory\\:\\ 0\\.03848824644154728\ \(0\)\
\-\ intensity\\:\\ 0\\.037666715565601236\ \(0\)\
\-\ malignant\\:\\ 0\\.037666715565601236\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.03735299737976665\ \(0\)\
\-\ spinal\\:\\ 0\\.03731434402901934\ \(0\)\
\-\ extension\\:\\ 0\\.037199113672946996\ \(0\)\
\-\ headache\\:\\ 0\\.03579250533616827\ \(0\)\
\-\ now\\:\\ 0\\.03562336085002009\ \(0\)\
\-\ radiation\\:\\ 0\\.034198185970272396\ \(0\)\
\-\ medial\\:\\ 0\\.03333292089743966\ \(0\)\
\-\ aspect\\:\\ 0\\.03273526749369948\ \(0\)\
\-\ enhancing\\:\\ 0\\.03268236015713121\ \(0\)\
\-\ severe\\:\\ 0\\.03206475365934151\ \(0\)\
\-\ brain\\:\\ 0\\.031357945406131245\ \(0\)\
\-\ 5\\:\\ 0\\.030489761249319066\ \(0\)\
\-\ lymphoma\\:\\ 0\\.029782910175481535\ \(0\)\
\-\ abnormal\\:\\ 0\\.029720637077011114\ \(0\)\
\-\ all\\:\\ 0\\.029474676700381595\ \(0\)\
\-\ lobe\\:\\ 0\\.02804055302345773\ \(0\)\
\-\ enhancement\\:\\ 0\\.02793278983076873\ \(0\)\
\-\ signal\\:\\ 0\\.027476516222838764\ \(0\)\
\-\ into\\:\\ 0\\.024796663023898866\ \(0\)\
\-\ imaging\\:\\ 0\\.02441553444458052\ \(0\)\
\-\ woman\\:\\ 0\\.02407198716449886\ \(0\)\
\-\ after\\:\\ 0\\.021560990275721982\ \(0\)\
\-\ presents\\:\\ 0\\.02128834506716983\ \(0\)\
\-\ as\\:\\ 0\\.015763140315782048\ \(0\)\
\-\ mass\\:\\ 0\\.01449342691399469\ \(0\)\
\-\ left\\:\\ 0\\.011659820356986766\ \(0\)\
\-\ year\\:\\ 0\\.011659820356986766\ \(0\)\
\-\ old\\:\\ 0\\.010669934108076276\ \(0\)\
\-\ a\\:\\ 0\\.009673165898014665\ \(0\)\
\-\ on\\:\\ 0\\.008827939175188147\ \(0\)\
\-\ with\\:\\ 0\\.00570752078487267\ \(0\)\
\-\ and\\:\\ 0\\.004390463554444352\ \(0\)\
\-\ \\,\\:\\ 0\\.003301342262405944\ \(0\)\
\-\ of\\:\\ 0\\.002841556117024108\ \(0\)\
\-\ \\.\\:\\ 0\\.002164605859594285\ \(0\)\
